← All stocks

IRADIMED CORP

IRMD Net selling
CIK 0001325618 #2472 in the set updated 17 Sep 2026
Bought (120 mo)
$208.32K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$94.11M
$23.94M on a plan · $31.70M straight out of an exercise
Sold at will
$38.46M
151 of 480 sales
Net
−$93.90M
−$38.25M against sales at will

By person

15 insiders · 487 transactions
1,745×

Roger Susi holds 1,745 times base salary in stock. $672.97M of shares against $385.60K in salary for 2025.

Salary from the company's own proxy. The shares are what Roger Susi last reported holding, valued at $86.35, the price Common Stock was last bought or sold at on the open market here, on 3 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Susi Roger E.
CEO, President, Chairman
$208.32K (5)
$52.88M (241)
−$52.67M
7,793,550
60.95%
$672.97M
−15.4%
JOHNSON BRENT
Exec. VP of WW Sales and Mktg
$17.59M (148) scheduled
−$17.59M
3,663
0.0286%
$316.30K
HAWKINS JAMES B
Director
$8.01M (31) scheduled
−$8.01M
29,647
0.2319%
$2.56M
+680.8%
Scott Christopher K.
CFO & Secretary
$4.90M (8) scheduled
−$4.90M
13,710
0.1072%
$1.18M
GLENN JOHN
CFO
$2.49M (4) scheduled
−$2.49M
11,937
0.0934%
$1.03M
Waldman Louis S.
Former Controller
$2.46M (8)
−$2.46M
38,901
0.3042%
$3.36M
−58.2%
Casey Francis X.
VP of Reg. and Qual. Assurance
$2.26M (3)
−$2.26M
53,474
0.4182%
$4.62M
−61.8%
ALLEN MONTY K
Director
$1.79M (18)
−$1.79M
19,581
0.1531%
$1.69M
+527.6%
VUOTO ANTHONY
Director
$908.25K (9)
−$908.25K
17,181
0.1344%
$1.48M
Nardi Steven M.
VP Manufacturing
$333.23K (6) scheduled
−$333.23K
0
0.0000%
$0.00
Scharen-Guivel Hilda Frederique
Director
$285.00K (2)
−$285.00K
5,598
0.0438%
$483.39K
McCreery John K
Chief Operating Officer
$191.11K (2)
−$191.11K
43,315
0.3387%
$3.74M
+441.4%
McDonnell Leslie L
Former CEO & Director
121,333
0.9489%
$10.48M
+142.7%
Kennedy Jonathan
Director
27,386
0.2142%
$2.36M
Chiprin Jeff
Chief Commercial Officer
687
0.0054%
$59.32K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 408
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 138
Sales straight out of an exercise 191
Sales at will 151
Transactions with no price 0
Shares from compensation/vesting 2,090,346
Sales filed before the plan box existed 85
History held since 2 Sep 2016